Archive \ Volume.13 2022 Issue 3

Self Medication in Today's Generation without Knowledge as Self Inflicted Harm

Jayavel Kavitha , Sivagnanam Sivakrishnan , Nagarajan Srinivasan

The simplest definition of self-medication is the use of drugs (medications) without a doctor's prescription. These drugs are sold in pharmacies and other shops and are referred to as 'Over the counter' or 'Non-prescription.' This phenomenon is rapidly evolving. People take medicines without a doctor's permission for many different reasons. During clinical consultations, some people want to cut down on the time and money they spend. Other people don't bother to see a doctor at all and self-medicate. Other things to think about could be personal issues, such as the fear of losing a job because of a diagnosed condition, mental illness, pain relief, sadness, or ignorance. Self-medication may seem like a good idea at first, but it's important to think about the risks. Self-medication can lead to drug addiction, allergies, habituation, disease worsening, the wrong diagnosis and dose, incapacity, and even death, so it's important not to do it. This is why you should never try to take your own medicine. In this study, the "seriousness" of self-medication is talked about. This review will help everyone who wants to avoid taking their own medicine.

How to cite:
Kavitha J, Sivakrishnan S, Srinivasan N. Self Medication in Today's Generation without Knowledge as Self Inflicted Harm. Arch. Pharm. Pract. 2022;13(3):16-22.
Kavitha, J., Sivakrishnan, S., & Srinivasan, N. (2022). Self Medication in Today's Generation without Knowledge as Self Inflicted Harm. Archives Of Pharmacy Practice, 13(3),16-22.

Download Citation

1.        International Pharmaceutical Federation. Joint statement by the International Pharmaceutical Federation and The World Self-Medication Industry; 1999. Available from: (Accessed May 8th, 2021)

2.        Bowen D, Kisuule G, Ogasawara H, Siregar CJP, Williams GA, Hall C, et al. Guidelines for the Regulatory Assessment of Medicinal Products for use in Self-Medication. WHO/EDM/QSM/00.1, Geneva: World Health Organization. 2000.

3.        Awad A, Eltayeb I, Thalib L, Matowe L. Self-medication with antibiotics and antimalarials in the community of Khartoum State, Sudan. J Pharm Pharm Sci. 2005;8(2):326-31.

4.        WHO. Guidelines for the regulatory assessment of medicinal products for use in self-medication; 2000. Available from: (Accessed May 6th, 2021).

5.        World Health Organization. The role of the pharmacist in self-care and self-medication. Report of the 4th WHO Consultative Group on the role of the pharmacist; 1998. Available from: (Accessed 10th May 2021).

6.        WHO. Benefits and risks of self-medication. Geneva, WHO Drug Inf. 2000;14:1-2.

7.        Asia. Self-Care in the Context of Primary Health Care: Report of the Regional Consultation Bangkok, Thailand, 7-9 January 2009. World Health Organization, Regional Office for South-East Asia; 2009.

8.        Hughes CM, McElnay JC, Fleming GF. Benefits and Risks of Self Medication. Drug Safety. 2001;24(14):1027-37. doi:10.2165/00002018-200124140-00002

9.        Montastruc JL, Bagheri H, Geraud T, Lapeyre-Mestre M. Pharmacovigilance of self-medication. Therapie. 1997;52(2):105-10.

10.      Sailler L, Pugnet G, Montastruc JL. Self-medication. Rev Prat.  2012;62(10):1463-7.

11.      Montastruc JL, Bondon-Guitton E, Abadie D, Lacroix I, Berreni A, Pugnet G, et al. Pharmacovigilance, risks and adverse effects of self-medication. Therapies. 2016;71(2):257-62. doi:10.1016/j.therap.2016.02.012

12.      Fainzang S. The Other Side of Medicalization: Self-Medicalization and Self-Medication. Cult Med Psychiatry. 2013;37(3):488-504. doi:10.1007/s11013-013-9330-2

13.      Carney A, Liang K. Medication and substance use and misuse in the elderly. InElder abuse 2020 Jan 1 (pp. 213-229). Academic Press. doi:10.1016/b978-0-12-815779-4.00010-0

14.      Amoako EP, Richardson-Campbell L, Kennedy-Malone L. Self-medication with over-the-counter drugs among elderly adults. J Gerontol Nurs. 2003;29(8):10-5. doi:10.3928/0098-9134-20030801-05.

15.      Pandey A, Kumar S. Antibiotic activity of antimicrobial metabolites produced from soil microorganisms: an overview. Int J Pharm Res Allied Sci. 2015;4(4):28-32.

16.      Alanazi AM, Alawfi AH, Alrashidi EFA, Alazmi SEM, Alharbi BBG, Alhowaish KF, et al. An Overview on Antibiotics Use in Endodontic Management. Pharmacophore. 2021;12(6):10-4.

17.      Lessenger JE, Feinberg SD. Abuse of Prescription and Over-the-Counter Medications. J Am Board Fam Med. 2008;21(1):45-54. doi:10.3122/jabfm.2008.01.070071

18.      Rosenfeld S. Prevalence, associated factors, and misuse of medication in the elderly: a review. Cad Saúde Pública. 2003;19(3):717-24. doi:10.1590/s0102-311x2003000300004

19.      Cranz H. Over-the-Counter Drugs. Drug Saf. 1990;5(Suppl 1):120-5. doi:10.2165/00002018-199000051-00019

20.      Caulin C, Cranz H.  Self-medication:  Is regulation needed from whom. Therapie. 2000;55(4):547-53.

21.      Tarone RE, Blot WJ, McLaughlin JK. Nonselective Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Gastrointestinal Bleeding: Relative and Absolute Risk Estimates from Recent Epidemiologic Studies. Am J Ther. 2004;11(1):17-25. doi:10.1097/00045391-200401000-00007

22.      Farid M, El-Setouhy DA, El-Nabarawi MA, El-Bayomi T. Particle engineering/different film approaches for earlier absorption of meloxicam. Drug Deliv. 2016;23(7):2309-17.

23.      Bismuth M, Oustric S, Boyer P, Escourrou B, Brillac T, Mesthe P, et al. Family pharmacy: survey of a sample of patients in Midi-Pyrénées. Therapies. 2011;66(2):131-4. doi:10.2515/therapie/2011008

24.      Tillement JP, Delaveau P. Self-medication and safety. Bull Acad Natl Med. 2007;191(8):1517-26. doi:10.1016/s0001-4079(19)32901-2

25.      Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm. 2014;5(1):19. doi:10.4103/0976-0105.128253

26.      Fainzang S. Managing Medicinal Risks in Self-Medication. Drug Saf. 2014;37(5):333-42. doi:10.1007/s40264-014-0153-z

27.      Fournier JP, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. Eur J Clin Pharmacol. 2012;68(11):1533-40. doi:10.1007/s00228-012-1283-9

28.      Berreni A, Montastruc F, Bondon‐Guitton E, Rousseau V, Abadie D, Durrieu G, et al. Adverse drug reactions to self-medication: a study in a pharmacovigilance database. Fundam Clin Pharmacol. 2015;29(5):517-20. doi:10.1111/fcp.12140

29.      Garnier R, Castot A, Gervais P, Efthymiou ML, Fournier E. Neurotoxic effects of nasopharyngeal sympathomimetic vasoconstrictions. Toxicol Lett. 1983;18:107. doi:10.1016/0378-4274(83)90494-0

30.      Olivier P, Dugué A, Montastruc JL. Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey. Therapies. 2003;58(4):361-6.

31.      Montastruc F, Montastruc G, Taudou MJ, Olivier-Abbal P, Montastruc JL, Bondon-Guitton E. Acute coronary syndrome after nasal spray of Oxymetazoline. Chest. 2014;146(6):e214-e5. doi:10.1378/chest.14-1873

32.      Queneau P, Chabot JM, Rajaona H, Boissier C, Grandmottet P. Iatrogénie observée en milieu hospitalier. À propos de 109 cas colliger à partir d’une enquête transversale de l’APNET. Analyse des causes et propositions de nouvelles mesures préventives. Bull Acad Natl Med. 1992;176(4):511-29.

33.      Montastruc F, Duguet C, Rousseau V, Bagheri H, Montastruc JL. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Eur J Clin Pharmacol. 2014;70(9):1123-7. doi:10.1007/s00228-014-1707-9

34.      Begaud B. Rates of Spontaneous Reporting of Adverse Drug Reactions in France. J Am Med Assoc. 2002;288(13):1588. doi:10.1001/jama.288.13.1588

35.      Ruiz M. Risks of Self-Medication Practices. Curr Drug Saf. 2010;5(4):315-23. doi:10.2174/157488610792245966.

36.      Abdullah I, Hassan THA, Alhudaif AS, Bahkali MA, Aleid SB, AlSunbul MM, et al. Literature Review on Pathogenesis and Treatment of Depression. Int J Pharm Res Allied Sci. 2019;8(4):91-6.

37.      Babagi HF, Aljifri NM, Dali RS, Jan NS, Alqahtani LM, Abusrrah WM, et al. An overview on unipolar major depression in adults diagnosis and management approach. Pharmacophore. 2020;11(6):20-5.

38.      Sargazi S, Namani E. Effectiveness of cognitive-behavioral family therapy in clinical symptoms of children with attention deficit/hyperactivity disorder and family functioning. Int J Pharm Res Allied Sci. 2016;5(3):547-52.

39.      Casteen EJ, Nielsen SR, Olson EA, Frederiks K, Rosso IM. Reexperiencing and anxious arousal symptoms in relation to volumes of thalamus nuclei in posttraumatic stress spectrum adults. Brain Behav. 2022;e2639. doi:10.1002/brb3.2639

40.      Alghamdi AM, Samman OY, Bahader WK, Bakhsh TA, Altuwaylib SM, Haider MA, et al. Cannabinoid Acute Intoxication, Diagnosis, and Management. Int J Pharm Res Allied Sci. 2021;10(4):42-6. doi:10.51847/CKqshEif0Y

41.      Chouhan K, Prasad SB. Self-medication and their consequences: A challenge to health professional. Asian J Pharm Clin Res. 2016;9(2):314-7.

42.      Khezri MB, Zarin N, Hosseini SA. Comparing the impact of diclofenac sodium, hydrocortisone and a combination of both on pain management after elective caesarean section under spinal anesthesia. Pharmacophore. 2018;9(5):8-12.